Ranging from sexual function among cancer patients to how lifetime estrogen exposure affects late-life cognition to state strategies to address opioid use, these were Contemporary OB/GYN's selections for the top gynecologic studies published in October 2019.
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More